Short CV
Florian Schödel is a professional with > 30 years large pharmaceutical, biotech industry and academic experience of leading teams in the development of vaccines and biologics.
His passion is preventative medicine and the use of modern science and technology for the improvement of public health – especially in the development of preventative and therapeutic vaccines and biologics.
As an experienced and successful pharmaceutical executive, he has a track record in running scientific and operational organizations, in business and strategic planning, for forming international strategic partnerships and alliances, in target identification and in all steps of clinical and pre-clinical development.
He has directed the design and execution of clinical studies for licensure and routinely interacts with international and national regulatory agencies.
He has led the clinical teams responsible for several successful vaccine filings.
A physician and microbiologist by training, Florian was a VP in Vaccines Clinical Research of Merck Research Laboratories.
Florian graduated in medicine at the Technical University, Munich, and earned doctorates in Transplantation Immunology and Medical Microbiology (Dr. med. Dr. med. habil.) from the University of Munich (LMU). He holds adjunct faculty appointments at the LMU and at the Biodesign Center of the ASU. Florian’s research at the Max-Planck Institute for Biochemistry, at Scripps, WRAIR and INSERM focused on hepatitis B and on novel recombinant vaccines against diseases such as hepB, malaria and typhoid.
Florian joined MRL in 1996 as Director Clinical Vaccine Research leading EU vaccine clinical trials and the clinical development of rotavirus, measles, mumps and rubella vaccines. As the clinical liaison to an EU joint venture (SP-MSD) he participated in the development of pediatric combination vaccines. He led clinical teams in vaccines and biologics and contributed to clinical and analytical research development.
Florian serves on a number of Scientific Advisory Boards.
